AzTrials
AzTrials

Critically IllFASTNCT02399267

Frequency of Screening and SBT Technique Trial

A study testing Once daily screening, Twice daily screening and PS SBTs in people with Critically Ill, run by Unity Health Toronto at 10 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The requirement for invasive mechanical ventilation is a defining feature of critical illness. Liberation or weaning is the process during which the work of breathing is transferred from the ventilator back to the patient. Approximately 40% of the time spent on mechanical ventilation is dedicated to weaning. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Critically Ill
What is being tested?
Once daily screening, Twice daily screening and PS SBTs
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
10 sitesin 2 countries
Study dates
Jul 2016to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • The investigators will include patients who are:
  • receiving invasive mechanical ventilation for >= 24 hours.
  • capable of initiating spontaneous breaths on Pressure Support (PS) or Proportional Assist Ventilation (PAV) or triggering breaths on volume or pressure Assist Control (AC), volume or pressure Synchronized Intermittent Mandatory Ventilation (SIMV) ± PS, Pressure Regulated Volume Control (PRVC) or (Airway Pressure Release Ventilation) APRV,
  • with a fraction of inspired oxygen (FiO2) of =< 70% and
  • with a positive end-expiratory pressure (PEEP) of =< 12 cm H2O.

Who cannot join

  • The investigators will exclude patients who are
  • admitted after cardiopulmonary arrest or with brain death or expected brain death,
  • who have evidence of myocardial ischemia in the 24 hour period before enrollment,
  • who have received continuous invasive mechanical ventilation for >= 2 weeks,
  • who have a tracheostomy in situ at the time of screening,
  • who are receiving sedative infusions for seizures or alcohol withdrawal,
Show all 15Show fewer
  • who require escalating doses of sedative agents,
  • who are receiving neuromuscular blockers or who have known quadriplegia, paraplegia or 4 limb weakness or paralysis preventing active mobilization (e.g., active range of motion, exercises in bed, sitting at edge of bed, transferring from bed to chair, standing, marching in place, ambulating),
  • who are moribund (e.g., at imminent risk for death) or who have limitations of treatment (e.g., withdrawal of support, do not reintubate order, however, do not resuscitate orders will be permitted),
  • who have profound neurologic deficits (e.g. large intracranial stroke or bleed) or Glasgow Coma Scale (GCS) < 6,
  • who are using modes that automate SBT conduct,
  • who are current enrolled in a confounding study that includes a weaning protocol, or
  • who were previously enrolled in this trial,
  • patients who have already undergone an SBT or who are on settings compatible with an SBT (T-piece, CPAP without PS (any level), or PS (=< 8 cm H2O regardless of PEEP)
  • patients who have already undergone extubation [planned, unplanned (e.g. self, accidental)] during the same ICU admission.

Trial locations and contacts

10 sites in 2 countries.

10 sites in 2 countries

Canada8 sites
  • Juravinski Hospital

    Hamilton, Ontario

  • St. Joseph's Hospital

    Hamilton, Ontario

  • Ottawa Civic Hospital

    Ottawa, Ontario

  • Ottawa General Hospital

    Ottawa, Ontario

  • Universite de Sherbrooke

    Sherbrooke, Quebec

  • St. Michael's Hospital

    Toronto, Ontario, M5B 1W8

  • St. Joseph's Hospital, Toronto

    Toronto, Ontario

  • St Paul's Hospital

    Vancouver, British Columbia

Other trials in Canada

United States2 sites
  • Grady Memorial Hospital

    Atlanta, Georgia

  • Longbeach Memorial Hospital

    Long Beach, California, 90806

Other trials in United States

About this study

Official title: The Frequency of Screening and SBT Technique Trial

The requirement for invasive mechanical ventilation is a defining feature of critical illness. Liberation or weaning is the process during which the work of breathing is transferred from the ventilator back to the patient. Approximately 40% of the time spent on mechanical ventilation is dedicated to weaning. Limiting the duration of invasive ventilation has been identified as a key research priority in critical care. Studies support the use of screening protocols (once daily vs. usual care) to identify weaning candidates and the conduct of tests of patient's ability to breathe spontaneously (SBTs). While once daily screening is the current standard of care in national intensive care units (ICUs), it is poorly aligned with the 24/7 ICU care environment wherein a critically ill patients' status can change from hour to hour. Only one large trial has compared alternative SBT techniques [T-piece vs PS (Pressure Support)]. No trial has compared a strategy of more frequent screening to once daily screening or alternative SBT techniques. The presence of respiratory therapists (RTs) 24/7 in North American ICUs presents a unique opportunity to screen more frequently, conduct more frequent SBTs, and determine the optimal strategy to liberate critically ill adults from invasive ventilation.

The investigators propose to conduct a pilot randomized trial in 100 critically ill adults comparing 'once daily' screening to 'at least twice daily' screening and PS vs. T-piece SBTs in 12 Canadian ICUs. In the proposed trial, the investigators will (i) assess their ability to recruit critically ill adults who can breathe spontaneously or initiate breaths on one of several commonly used modes of ventilation into the trial, (ii) evaluate clinician's ability to implement the trial as designed, (iii) assess current practices in sedation, analgesia and delirium management and timing of patient mobilization prior to conducting screening assessments, (iv) identify barriers (clinician, institutional) to enrolling patients, (v) characterize trial participants based on weaning difficulty, and (vi) obtain preliminary estimates of the impact of the alternative screening and SBT strategies on clinically important outcomes.

Read the detailed description

Identifying the optimal time when patients are ready to be weaned from invasive ventilation is challenging and often arbitrary. To identify weaning candidates, current guidelines recommend that clinicians use a combination of subjective clinical assessments and objective measurements. However, clinician's subjective assessments of weaning readiness underestimate the probability that patients can be successfully liberated from mechanical ventilation. Even the most objective measurement, the respiratory frequency to tidal volume ratio or rapid shallow breathing index (f/VT), has only limited value [Likelihood ratio + 1.58 (1.30 -1.90)] in predicting successful extubation after a trial of spontaneous breathing trial (SBT).

More than two decades of research support the use of specific strategies to limit the duration of invasive ventilation including the (i) use of multidisciplinary screening protocols to identify SBT candidates, (ii) conduct of SBTs in patients who meet screening criteria, and (iii) use of specific modes and techniques Pressure Support (PS) and once daily SBTs [e.g., PS or T-piece (no support)] to discontinue support in patients who fail an initial SBT and require weaning. Compared to usual care, earlier trials have shown that protocolized weaning, led by allied health care providers (RTs, nurses) reduced weaning time.

A systematic review and meta-analysis of 11 trials involving 1,971 critically ill patients, conducted by one investigative member of the study team (KB), demonstrated that screening protocols reduce the total duration of mechanical ventilation, the time spent weaning and ICU length of stay. Only 1 trial (n=385) compared twice daily screening led by RTs and bedside nurses to usual care (requiring a physician order to conduct an SBT) and found a significantly shorter duration of ventilation and a trend toward a lower ventilator-associated pneumonia (VAP) rate in the twice daily screening group. The investigator's prior work demonstrates that once daily screening is the current standard of care nationally and internationally.

Further, no trial has compared two of the most frequently used SBT techniques internationally [PS and T-piece]. Consequently, little is known about how frequently patients should be screened and what technique should be used to conduct SBTs in Canadian ICUs today. The FAST trial will address these important gaps in knowledge.

The proposed study is novel in seeking to identify the optimal screening and SBT strategies to minimize patients' exposure to invasive ventilation and the complications associated with it. It will evaluate how weaning strategies are delivered to critically ill adults and determine whether alternative delivery strategies may improve patient outcomes. Only one weaning trial has been conducted in Canada previously by members of the investigative team (KB, MM). Establishing the role for more frequent screening is appealing to ICU clinicians (intensivists, RTs, nurses, physiotherapists) because it is a sensible and low-risk intervention that represents a cost-effective use of current resources. Moreover, this simple intervention holds promise as a strategy that could change clinical practice, enhance the care delivered to critically ill adults, and improve patient outcomes.

In the FAST Trial,eligible patients will be randomized to a screening frequency (once vs. at least twice daily) and an SBT technique (PS vs. T-piece). The investigators propose to evaluate the feasibility of conducting an open-label, multicentre, factorial design trial involving 100 critically ill adults which compares screening frequency and SBT technique in 12 Canadian ICUs. In the pilot trial, the investigators will (i) evaluate their ability to recruit the desired population, (ii) assess clinician adherence to the screening and SBT protocols, (iii) identify potential confounders, (iv) characterize trial participants based on weaning difficulty, and (iv) obtain preliminary estimates of the effect of the alternative screening and SBT strategies on important outcomes.

In the pilot trial, the investigative team will also assess 'current practices' with regard to sedation, analgesia, and delirium management, as well as, timing of mobilization prior to screening assessments to identify practices that may bias duration of ventilation and require protocolization in the future, planned large scale weaning trial. All participating adult ICUs currently titrate sedation use to either the Sedation-Agitation Scale (SAS) or Richmond Agitation Sedation Scale (RASS), have dedicated RT personnel present 24 hours per day/7 days per week and have either full time, part time, or consulting Physiotherapists.

The investigators will determine if the proposed multicentre screening randomized control trial (RCT) is:

  1. Feasible, specifically, can the investigative team:
  2. Recruit critically ill adults breathing spontaneously on Pressure Support (PS) or proportional assist ventilation (PAV), or triggering breaths on volume or pressure Assist Control (AC), volume or pressure Synchronized Intermittent Mandatory Ventilation (SIMV) ± PS, Pressure Regulated Volume Control (PRVC) or Airway Pressure Release Ventilation (APRV) into a trial comparing 'once daily' to 'at least twice daily' screening to identify weaning candidates,
  3. Comply with 'once daily' and 'at least twice daily' screening assessment protocols with minimal contamination in 'once daily' arm,
  4. Comply with PS and T-piece SBT protocols with minimal contamination in either arm,
  5. Quantify potential co-interventions (sedation, analgesia and delirium management and timing of mobilization) that may lead to performance bias and may require protocolization in the future, planned, large scale weaning trial,
  6. Identify barriers (clinician and institutional) to recruitment,
  7. Classify trial participants as those requiring (i) simple, (ii) difficult or (iii) prolonged weaning using established definitions,
  8. Obtain preliminary estimates of the impact of the alternative screening ('once daily' vs. 'at least twice daily') and SBT techniques (PS vs. T-piece) on important outcomes [e.g., time to first SBT and first successful SBT, time to first extubation and successful extubation, total duration of mechanical ventilation, ICU and hospital length of stay, ICU and hospital mortality, the use of noninvasive ventilation (NIV) after extubation
  9. Safe, with regard to the proportion of patients experiencing weaning related complications (self-extubation, reintubation, tracheostomy) in both screening and SBT strategies.

Information obtained from the pilot trial will inform the design of the planned large scale trial evaluating the time to first successful SBT completion (SBT outcome) and the time to first successful extubation (weaning and extubation outcome). In this manner, the investigators will assess the feasibility of conducting a multicentre, multinational RCT addressing this important research question.

Conditions
Critically Ill
Being tested
Once daily screening, Twice daily screening, PS SBTs, T-piece SBTs
Keywords
mechanical ventilation, weaning, critically ill, spontaneous breathing trial, screening, invasive ventilation, SBT technique
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Once daily screeningProcedure or surgery

    RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.

  • Twice daily screeningProcedure or surgery

    In the 'at least twice daily' screening arm patients will be screened at a minimum between approximately 6:00-8:00 hours and 13:00-15:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.

  • PS SBTsProcedure or surgery

    Patients are assigned a SBT technique. All SBTs for these patients must be conducted on PS =< 8 cm H2O with PEEP =< 5 cm H2O.

  • T-piece SBTsProcedure or surgery

    Patients are assigned a SBT technique. All SBTs for these patients must be conducted with T-piece.

Study groups in NCT02399267
Study groupRoleWhat they receive
Once daily screeningActive comparatorIn the 'once daily screening arm', RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hours of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol.
Receives: Procedure: Once daily screening
At least twice daily screeningExperimentalIn the 'at least twice daily' screening arm patients will be screened at a minimum between approximately 06:00 - 08:00 hours and 13:00 - 15:00 hours daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hours of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team (RTs and physicians). Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol.
Receives: Procedure: Twice daily screening
PS SBTsActive comparatorIn the 'PS SBTs arm', RTs will conduct SBTs using only PS =< 8 cm H2O with PEEP =< 5 cm H2O. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol.
Receives: Procedure: PS SBTs
T-piece SBTsActive comparatorIn the 'T-piece SBTs arm', RTs will conduct SBTs using only T-piece. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol.
Receives: Procedure: T-piece SBTs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment metrics as measured by number of critically ill patients enrolled per ICU per month

    Assess the investigative team's ability to recruit, on average, 2 invasively ventilated, critically ill adults who can breathe spontaneously or initiate breaths on one of several commonly used modes of ventilation into the trial, per ICU ment per month.

    Measured: 24 Months

Secondary outcomes (5)
  1. Adherence to protocol as measured by rate of protocol violations

    Evaluate clinician's ability to implement the trial as designed

    Measured: 24 Months

  2. Current practices regarding sedation, analgesics, delirium and mobilization as assessed using a checklist prior to screening

    Assess current practices in sedation, analgesia and delirium management and timing of patient mobilization prior to conducting screening assessments

    Measured: 24 Months

  3. Enrollment Barriers as measured by consent rates and presence of exclusion criteria

    Identify barriers (clinician, institutional) to enrolling patients, (v) characterize trial participants based on weaning difficulty

    Measured: 24 Months

  4. Characterize Weaning as simple, difficult or prolonged according to the Task Force on Weaning definitions

    Characterize trial participants based on weaning difficulty

    Measured: 24 Months

  5. Clinically Important Outcomes

    Obtain preliminary estimates of the impact of the alternative screening and SBT strategies on clinically important outcomes (i.e. time to first SBT and first successful SBT, time to first extubation and successful extubation, total duration of mechanical ventilation, ICU and hospital length of stay, ICU and hospital mortality, the use of noninvasive ventilation (NIV) after extubation).

    Measured: 24 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2015 (estimated)
  2. Study startJul 2016
  3. Primary completionDec 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02399267
Sponsor's protocol ID
FAST-001
Acronym
FAST
Status last verified
Apr 2019
First submitted
15 Mar 2015
Last updated
4 Apr 2019
Results posted
No
Data monitoring committee
No

Publications

  • Burns KEA, Wong J, Rizvi L, Lafreniere-Roula M, Thorpe K, Devlin JW, Cook DJ, Seely A, Dodek PM, Tanios M, Piraino T, Gouskos A, Kiedrowski KC, Kay P, Mitchell S, Merner GW, Mayette M, D'Aragon F, Lamontagne F, Rochwerg B, Turgeon A, Sia YT, Charbonney E, Aslanian P, Criner GJ, Hyzy RC, Beitler JR, Kassis EB, Kutsogiannis DJ, Meade MO, Liebler J, Iyer-Kumar S, Tsang J, Cirone R, Shanholtz C, Hill NS; Canadian Critical Care Trials Group. Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial. JAMA. 2024 Dec 3;332(21):1808-1821. doi: 10.1001/jama.2024.20631.

    PubMed 39382222
  • Burns KEA, Lafrienier-Roula M, Hill NS, Cook DJ, Seely AJE, Rochwerg B, Mayette M, D'Aragon F, Devlin JW, Dodek P, Tanios M, Gouskos A, Turgeon AF, Aslanian P, Sia YT, Beitler JR, Hyzy R, Criner GJ, Kassis EB, Tsang JLY, Meade MO, Liebler JM, Wong JTY, Thorpe KE; Canadian Critical Care Trials Group. Frequency of screening and SBT Technique Trial-North American Weaning Collaboration (FAST-NAWC): an update to the protocol and statistical analysis plan. Trials. 2023 Oct 2;24(1):626. doi: 10.1186/s13063-023-07079-5.

    PubMed 37784109
  • Burns KEA, Rizvi L, Cook DJ, Seely AJE, Rochwerg B, Lamontagne F, Devlin JW, Dodek P, Mayette M, Tanios M, Gouskos A, Kay P, Mitchell S, Kiedrowski KC, Hill NS; Canadian Critical Care Trials Group. Frequency of Screening and SBT Technique Trial - North American Weaning Collaboration (FAST-NAWC): a protocol for a multicenter, factorial randomized trial. Trials. 2019 Oct 11;20(1):587. doi: 10.1186/s13063-019-3641-8.

    PubMed 31604480

Questions about this trial

What is this clinical trial studying?

A study testing Once daily screening, Twice daily screening and PS SBTs in people with Critically Ill, run by Unity Health Toronto at 10 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in Canada, United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment metrics as measured by number of critically ill patients enrolled per ICU per month (time frame: 24 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02399267, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in